BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
187 hedge funds and large institutions have $1.71B invested in bluebird bio in 2016 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 81 increasing their positions, 48 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $2.53B → $1.71B (-$819M)
46% less call options, than puts
Call options by funds: $16.8M | Put options by funds: $31M
Holders
187
Holding in Top 10
4
Calls
$16.8M
Puts
$31M
Top Buyers
| 1 | +$51.1M | |
| 2 | +$16.7M | |
| 3 | +$10.7M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$10.5M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.4M |
Top Sellers
| 1 | -$42.9M | |
| 2 | -$31.2M | |
| 3 | -$16.7M | |
| 4 |
Capital Fund Management (CFM)
Paris,
France
|
-$16.6M |
| 5 |
State of Tennessee, Department of Treasury
Nashville,
Tennessee
|
-$12.3M |